This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal

Xofigo®▼ (radium-223 dichloride) Resources

Xofigo Header Image
Xofigo-Patient-Booklet

Patient Booklet

Download Here
Xofigo Treatment Diary

Treatment Diary

Download Here
Xofigo MI patient booklet

Patient Counselling Booklet

Download Here
Xofigo Pocket Treatment Guide

Pocket Treatment Guide

Download Here
Xofigo Patient Alert Card

Patient Alert Card

Click below to send your request for a printed copy of this Xofigo Patient Alert Card

Submit Request Here

Patient support video for Xofigo patients

Xofigo▼ Prescribing Information
Oncology Homepage
Welcome to the home of Bayer Oncology
PP-PF-ONC-GB-0398, February 2024
Xofigo®▼ (radium-223 dichloride)
In mCRPC
PP-XOF-GB-0648, April 2025
Xofigo®▼ (radium-223 dichloride) Guidelines
PP-XOF-GB-0636, March 2025

PP-XOF-GB-0626 | April 2025